Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer
Sign Up to like & getrecommendations! Published in 2023 at "Chemotherapy"
DOI: 10.1159/000528867
Abstract: Introduction Trifluridine/tipiracil hydrochloride (FTD/TPI, Lonsurf®) is an oral antineoplastic agent that has been approved as late-stage chemotherapy for colorectal cancer. Its major mechanism of action is the dysfunction of tumoral DNA including DNA strand breaks… read more here.
Keywords: ftd tpi; colorectal cancer; combination; tpi fruquintinib ... See more keywords